A detailed history of Riverview Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Riverview Trust CO holds 2,577 shares of LLY stock, worth $2.36 Million. This represents 1.56% of its overall portfolio holdings.

Number of Shares
2,577
Previous 2,577 -0.0%
Holding current value
$2.36 Million
Previous $1.5 Million 33.42%
% of portfolio
1.56%
Previous 1.54%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 25, 2023

BUY
$321.55 - $374.67 $13,826 - $16,110
43 Added 1.7%
2,577 $943,000
Q2 2022

Jul 27, 2022

BUY
$278.73 - $327.27 $5,574 - $6,545
20 Added 0.8%
2,534 $822,000
Q1 2022

Apr 21, 2022

BUY
$234.69 - $291.66 $133,538 - $165,954
569 Added 29.25%
2,514 $720,000
Q3 2020

Oct 15, 2020

SELL
$146.22 - $169.13 $51,177 - $59,195
-350 Reduced 15.25%
1,945 $288,000
Q1 2020

Apr 15, 2020

BUY
$119.05 - $147.35 $5,952 - $7,367
50 Added 2.23%
2,295 $318,000
Q4 2018

Feb 12, 2019

BUY
$105.9 - $118.64 $237,745 - $266,346
2,245 New
2,245 $260,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $869B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Riverview Trust CO Portfolio

Follow Riverview Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverview Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Riverview Trust CO with notifications on news.